Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Creso Pharma Yönetim

Yönetim kriter kontrolleri 1/4

Creso Pharma's CEO'su Will Lay, Jan2022 tarihinde atandı, in görev süresi 1.08 yıldır. şirketin hisselerinin 0.63% doğrudan sahiptir ve bu hisselerin değeri A$ 199.35K dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.1 yıl ve 1.2 yıldır.

Anahtar bilgiler

Will Lay

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	1.1yrs
CEO sahipliği	0.6%
Yönetim ortalama görev süresi	4.1yrs
Yönetim Kurulu ortalama görev süresi	1.2yrs

Son yönetim güncellemeleri

Recent updates

CEO

Will Lay

1.1yrs

Görev süresi

Mr. William Lay, also known as Will, B.Com (Hons.) serves as Group Chief Executive Officer, Managing Director and Director at Creso Pharma Limited since January 17, 2022 and served as its Executive Vice Pr...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Boaz Wachtel	Co-Founder & Non-Executive Chairman	7.3yrs	AU$167.14k	0.10% A$ 31.9k
Christopher Grundy	Chief Financial Officer	5.3yrs	AU$501.65k	0.047% A$ 15.0k
William Lay	Group CEO	1.1yrs	Veri yok	0.63% A$ 199.4k
Gian Trepp	Commercial & Marketing Director	4.1yrs	Veri yok	Veri yok
Micheline MacKay	MD & Executive Director	1.1yrs	Veri yok	Veri yok
Jodi Scott	Executive Director & President of US Operations	less than a year	Veri yok	10.48% A$ 3.3m
Erlyn Dawson	Joint Company Secretary	4.3yrs	Veri yok	Veri yok
Winton Willesee	Joint Company Secretary	4.3yrs	Veri yok	Veri yok
Simon H. Buckingham	Consultant	5.7yrs	AU$18.38k	Veri yok
Brian Walker	Strategic Consultant & Chair of Scientific Advisory Committee	1.3yrs	Veri yok	Veri yok

4.1yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: CPHOA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.1 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Boaz Wachtel	Co-Founder & Non-Executive Chairman	7.3yrs	AU$167.14k	0.10% A$ 31.9k
William Lay	Group CEO	1.1yrs	Veri yok	0.63% A$ 199.4k
Micheline MacKay	MD & Executive Director	1.1yrs	Veri yok	Veri yok
Jodi Scott	Executive Director & President of US Operations	less than a year	Veri yok	10.48% A$ 3.3m
Brian Walker	Strategic Consultant & Chair of Scientific Advisory Committee	1.3yrs	Veri yok	Veri yok
Walter Von Wartburg	Member of Scientific Advisory Board	4.1yrs	Veri yok	Veri yok
Bruce Linton	Independent Non-Executive Director & Strategic Advisor	2.3yrs	Veri yok	0.52% A$ 166.1k
Isaac Kobrin	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Felix Gutzwiller	Member of Scientific Advisory Board	5.9yrs	Veri yok	Veri yok
Peter Hatfull	Non-Executive Director	less than a year	Veri yok	Veri yok
Ben Quirin	Non-Executive Director	less than a year	Veri yok	Veri yok

1.2yrs

Ortalama Görev Süresi

71.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CPHOA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.2 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Creso Pharma Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Melodiol Global Health Limited, Annual General Meeting, May 31, 2024

Melodiol Global Health Limited Announces Resignation of Erlyn Dawson as Joint Company Secretary

Creso Pharma Limited Announces Board Changes

Creso Pharma Limited Announces Director Appointments

Creso Pharma Limited Announces Board Changes

Creso Pharma Limited, Annual General Meeting, May 31, 2022

Recent updates

Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 3 million.

Melodiol Global Health Limited has filed a Follow-on Equity Offering in the amount of AUD 3 million.

Melodiol Global Health Limited, Annual General Meeting, May 31, 2024

Melodiol Global Health Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.

Melodiol Global Health Limited Option Expiring 13 November 2028 Deferred Settlement Deleted from OTC Equity

Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 0.215 million.

Melodiol Global Health Limited Announces Resignation of Erlyn Dawson as Joint Company Secretary

Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 0.231808 million.

Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 1.022261 million.

Melodiol Global Health Limited has completed a Follow-on Equity Offering in the amount of AUD 1.022261 million.

Melodiol Global Health Limited has filed a Follow-on Equity Offering in the amount of AUD 1.010906 million.

Panacea Life Sciences Holdings, Inc. (OTCPK:PLSH) entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.

Creso Pharma Limited (ASX:CPH) entered into a binding letter of intent to acquire Abby & Finn, LLC for $2.5 million.

Creso Pharma Limited Announces Board Changes

Creso Pharma Limited Announces Director Appointments

Creso Pharma Limited Announces Board Changes

Sierra Sage Secures USD 214,000 Purchase Order from Walmart

Creso Pharma Limited (ASX:CPH) signed a non-binding, non-exclusive heads of agreement to acquire Dr Pickles Pty Ltd.

Creso Pharma Limited, Annual General Meeting, May 31, 2022

Creso Pharma Limited announced that it expects to receive AUD 5 million in funding

Creso Pharma to Develop New Hemp-Based Lozenge Product

Creso Pharma Limited Launches New E-Commerce Channels

Creso Pharma Limited (ASX:CPH) completed the acquisition of Halucenex Life Sciences Inc.

Creso Pharma Limited Launches New Product

Creso Pharma Limited (ASX:CPH) entered into an agreement to acquire Halucenex Life Sciences Inc. CAD 10 million.

Creso Pharma Limited Signs Non-Binding Letter of Intent with ImpACTIVE Holdings Ltd

Creso Pharma Limited Executes A Non-Binding Letter of Intent with Ceres Natural Remedies

Creso Pharma Limited Revises Earnings Guidance for the Fiscal Year 2021

Creso Pharma Limited Announces Distribution Agreement with Route2 Pharm Pvt Ltd

CBD Oil legal in Australia - Creso Pharma Limited to benefit

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş